Bromopride stimulates 5-HT4-serotonin receptors in the human atrium
Open Access
- 17 March 2025
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 398 (9) , 12003-12013
Abstract
Bromopride, an analogue of metoclopramide, is approved in some countries to treat gastrointestinal diseases. These therapeutic effects of bromopride are explained by antagonism at D2-dopamine receptors in the gut and the brain. We tested here the hypothesis that bromopride acts as an agonist or antagonist at the human cardiac 5-HT4-serotonin receptors. To this end, the force of contraction (FOC) was measured in isolated human atrial preparations (HAP), in isolated left atrial preparations (LA), and in isolated spontaneously beating right atrial (RA) preparations from mice with cardiac specific overexpression of the human 5-HT4-serotonin receptors (5-HT4-TG). Bromopride concentration dependently increased FOC in LA from 5-HT4-TG. The positive inotropic effect (PIE) of bromopride in LA from 5-HT4-TG was abolished by GR125487, a 5-HT4-serotonin receptor antagonist. Only in the presence of the phosphodiesterase III inhibitor cilostamide did bromopride raise FOC under isometric conditions in HAP. The PIE of 10 µM bromopride in HAP was extinguished by 1 µM GR125487. When serotonin had elevated FOC in HAP, additionally applied bromopride reduced FOC. These data suggest that bromopride is a partial agonist at human cardiac 5-HT4-serotonin receptors.Keywords
Funding Information
- Martin-Luther-Universität Halle-Wittenberg
This publication has 44 references indexed in Scilit:
- Impact of phosphodiesterases PDE3 and PDE4 on 5-hydroxytryptamine receptor4-mediated increase of cAMP in human atrial fibrillationNaunyn-Schmiedeberg's Archives of Pharmacology, 2020
- Which phosphodiesterase can decrease cardiac effects of 5-HT4 receptor activation in transgenic mice?Naunyn-Schmiedeberg's Archives of Pharmacology, 2019
- Cardiovascular effects of cisapride and prucalopride on human 5-HT4 receptors in transgenic miceNaunyn-Schmiedeberg's Archives of Pharmacology, 2018
- Human 5-HT4 receptor stimulation in atria of transgenic miceNaunyn-Schmiedeberg's Archives of Pharmacology, 2013
- Phosphorylation of phospholamban and troponin I through 5-HT4 receptors in the isolated human atriumNaunyn-Schmiedeberg's Archives of Pharmacology, 2008
- Cilostamide potentiates more the positive inotropic effects of (−)-adrenaline through β2-adrenoceptors than the effects of (−)-noradrenaline through β1-adrenoceptors in human atrial myocardiumNaunyn-Schmiedeberg's Archives of Pharmacology, 2006
- Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failureNaunyn-Schmiedeberg's Archives of Pharmacology, 2004
- 5-Hydroxytryptamine causes rate-dependent arrhythmias through 5-HT4 receptors in human atrium: facilitation by chronic β-adrenoceptor blockadeNaunyn-Schmiedeberg's Archives of Pharmacology, 1994
- Positive inotropic response to 5-HT in human atrial but not in ventricular heart muscleNaunyn-Schmiedeberg's Archives of Pharmacology, 1992
- Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparationsNaunyn-Schmiedeberg's Archives of Pharmacology, 1991